Sunitinib Malate After Stereotactic Radiosurgery in Treating Patients With Newly Diagnosed Brain Metastases
Stopped Slow Accrual
Conditions
- Cognitive/Functional Effects
- Metastatic Cancer
- Unspecified Adult Solid Tumor, Protocol Specific
Interventions
- DRUG: sunitinib malate
- OTHER: cognitive assessment
Sponsor
Case Comprehensive Cancer Center
Collaborators